Intrapharm Labs

Cookham, United Kingdom Founded: 1999 • Age: 27 yrs Acquired By RIEMSER Pharma
OTC products manufacturer and supplier

About Intrapharm Labs

Intrapharm Labs is a Healthcare company based in Cookham (United Kingdom) founded in 1999, and was acquired by RIEMSER Pharma in November 2015. OTC products manufacturer and supplier. Intrapharm Labs has raised $3.32 million across 2 funding rounds from investors including RIEMSER Pharma and BGF. Intrapharm Labs has completed 1 acquisition, including Peckforton Pharmaceuticals. Its focus areas include Traditional Pharmaceuticals.

Company details

Intrapharm Laboratories is a speciality pharmaceutical focussed on the manufacturing and supply of OTC products to both the UK and Republic of Ireland. It has provided services for the supply of pharmaceutical products with proven therapeutic value and medical need addressing therapeutic areas covering oncology, ophthalmology, pain, gastrointestinal and dermatology. Its products include Lactulose Sachets, Terra Cortril, Carbocisteine Sachets, Triamcinolone Hexacetonide, Naltrexone Implants and Generics. In November 2015, Riemser Pharma acquired Intrapharm Laboratories.

  • Headquarters Cookham, United Kingdom
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website intrapharmlabs.com
  • Social LinkedIn X
  • Acquired by RIEMSER Pharma (Nov 2015)
Key Metrics

Funding Insights of Intrapharm Labs

Intrapharm Labs has successfully raised a total of $3.32M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.32M
  • Total Rounds 2
  • First Round $3.32M

    (Aug 2014)

  • Investors Count 1

All 2 funding rounds of Intrapharm Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2014Debt – Conventional––
–
Aug 2014$3.32MSeries A––
Valuation history

2 investors in total: 2 institutional.

Investors in Intrapharm Labs

Intrapharm Labs has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include RIEMSER Pharma and BGF.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland
bgf.co.ukBelfast, United Kingdom
Contract development and manufacturing services for pharmaceutical APIs are provided.
2000riemser.comGreifswald, Germany
Premium access

Investor details for Intrapharm Labs

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Intrapharm Labs

Intrapharm Labs has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Peckforton Pharmaceuticals.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Prescription and OTC products for gastrointestinal conditions are manufactured.
peckforton.comCheshire, United States1998Aug 2014β€’β€’β€’β€’
Premium access

Complete acquisition details for Intrapharm Labs

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Intrapharm Labs

5 dated milestones of Intrapharm Labs across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Intrapharm Labs is founded.
  2. Funding First funding round of $3.3M.
  3. Acquisition Acquires Peckforton Pharmaceuticals.
  4. Funding Latest funding round, Debt – Conventional,.
  5. Exit Acquired by RIEMSER Pharma.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Intrapharm Labs

Intrapharm Labs was founded in 1999 and raised its 1st funding round 15 years after it was founded.

Intrapharm Labs is headquartered in Cookham, United Kingdom.

Intrapharm Labs is a funded company, having raised a total of $3.32M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.32M, raised on Aug 2014.

Intrapharm Laboratories is a speciality pharmaceutical focussed on the manufacturing and supply of OTC products to both the UK and Republic of Ireland. It has provided services for the supply of pharmaceutical products with proven therapeutic value and medical need addressing therapeutic areas covering oncology, ophthalmology, pain, gastrointestinal and dermatology. Its products include Lactulose Sachets, Terra Cortril, Carbocisteine Sachets, Triamcinolone Hexacetonide, Naltrexone Implants and Generics. In November 2015, Riemser Pharma acquired Intrapharm Laboratories.

Intrapharm Labs has made 1 acquisition, including Peckforton Pharmaceuticals.

Intrapharm Labs has 2 investors. Key investors include RIEMSER Pharma, and BGF.

Yes. Intrapharm Labs was acquired by RIEMSER Pharma in November 2015.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available